| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Rallis Chris A is a Director at FENNEC PHARMACEUTICALS INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $571K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 269 | $8.25 | $2,219.25 | -0.6% | +3.3% | -49.9% | |
| Aug 18, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 673 | $7.85 | $5,283.05 | -1.5% | +3.2% | -29.0% | |
| Jul 24, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 6,796 | $8.17 | $55,523.32 | -13.4% | -16.3% | -17.5% | |
| Jul 6, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sale+OE | 2,207 | $8.47 | $18,693.29 | -7.1% | -24.4% | -32.3% | |
| May 19, 2023 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 1,758 | $7.36 | $12,938.88 | -2.7% | +5.8% | -5.8% | |
| Nov 17, 2022 | FENC Fennec Pharmaceuticals Inc. | Director | Sell | 333 | $7.99 | $2,660.67 | -1.1% | +15.5% | +1.6% |